Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares International Treasury Bond ETF (IGOV) vs Altria Group Inc (MO) Price & Performance

iShares International Treasury Bond ETFTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

iShares International Treasury Bond ETF vs Altria Group Inc — how do they compare? iShares International Treasury Bond ETF trades at $39.74 (market cap $1.30B), while Altria Group Inc trades at $71.68 (market cap $119.25B). The key difference: Altria Group Inc is far larger — about 91.7× iShares International Treasury Bond ETF's market cap, and Altria Group Inc pays a 6.22% dividend while iShares International Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares International Treasury Bond ETF for 92 Days and Altria Group Inc for 154 Days on average.

IGOVMO
Market Cap
$1.30B$119.25B
Volume
693,74011,178,169
Sector
Fixed IncomeConsumer Staples
52-Week High
$42.99$74.92
52-Week Low
$39.65$54.72
Typical Hold Time
92 Days154 Days
Enterprise Value
—$141.46B
Dividend Yield
—6.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares International Treasury Bond ETF

IGOV trades at $39.74 with minimal daily movement (+0.1%). Technical indicators show a bearish bias with moving averages signaling selling pressure, though oscillators remain neutral. The stock faces resistance at $40 across multiple levels, indicating consolidation. Financial ratios are unavailable in current data, limiting fundamental assessment of valuation and profitability metrics.

The bearish technical setup suggests near-term caution, though neutral RSI readings indicate potential stabilization. Rising bond yields create macroeconomic headwinds for equities, but specific company fundamentals require updated SEC filings for proper evaluation. Investment appeal hinges on upcoming earnings clarity amid broader market volatility.

Altria Group Inc

Altria Group (MO) trades at $71.43, up 2.95% with a bullish technical signal and strong cash flow generation. The stock shows mixed earnings performance with two misses and one beat in recent quarters, while maintaining a 39% net income margin and $9.3B operating cash flow. Recent news highlights the company's 6.6% dividend yield and 60 consecutive annual increases, though some analysts express concerns about negative equity and regulatory challenges.

MO presents a compelling income opportunity with its high dividend yield and consistent payout history, but faces headwinds from declining cigarette volumes and regulatory uncertainty. The stock trades below analyst consensus target of $69.71, offering potential upside if the company successfully navigates its smoke-free transition. Key risks include negative shareholder equity and margin pressure from shifting consumer preferences.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IGOV

No sentiment data available yet.

MO
9% Buy91% Sell
Avg holding period · 154 Days

About iShares International Treasury Bond ETF

The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.

Read more on IGOV →

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO →